Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Eugia Pharma Specialities Limited
FDA Inspection
•Eugia Pharma Specialities Limited•February 6, 2026

Eugia Pharma Specialities Limited – FDA Inspection, Feb 6, 2026

Record Details

This FDA Inspection record concerns Eugia Pharma Specialities Limited, with an inspection on February 6, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company
Eugia Pharma Specialities Limited
Inspection Date
February 6, 2026
Product Type
Human Drugs
Office
Office of Inspections and Investigations
People
  • Anne P. Reid (FDA Associated Person)
  • Lisa L. Flores (Investigator)
  • Mark L. Baum
  • Patty P. Kaewussdangkul (FDA Associated Person)
  • Unnee Ranjan (FDA Associated Person)
View Company Profile

ID · dad2a99c-72eb-441c-b664-de937e749c6e

Inspection Facts

Inspection number
1301166
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

11
  1. 21 CFR 211.113(b)Procedures for sterile drug products
  2. 21 CFR 211.113(b)Validation lacking for sterile drug products
  3. 21 CFR 211.160(a)Following/documenting laboratory controls
  4. 21 CFR 211.165(a)Testing and release for distribution
  5. 21 CFR 211.167(a)Sterility/pyrogens - test methods written, followed
  6. 21 CFR 211.192Investigations of discrepancies, failures
  7. 21 CFR 211.194(a)(8)Second person sign off
  8. 21 CFR 211.22(d)Procedures not in writing, fully followed
  9. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  10. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Eugia Pharma Specialities Limited

7
DateClassificationOfficeProject area
February 2, 2024OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 14, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 20, 2018VAICenter for Drug Evaluation and ResearchGeneric Drug Evaluation
April 28, 2017Not classifiedOffice of Inspections and InvestigationsGeneric Drug Evaluation
September 16, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Eugia Pharma Specialities Limited
  • FDA Inspection 1228546 - 2024-02-02
  • FDA Inspection 1074573 - 2018-12-14
  • FDA Inspection 1041554 - 2018-02-20
  • FDA Inspection 1010785 - 2017-04-28
  • FDA Inspection 989530 - 2016-09-16

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Eugia Pharma Specialities Limited
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.